Cipla

In News

Cipla’s distribution edge turns Lilly-licensed Tirzepatide brand into growth machine - TradingView

TradingView - Jul 16, 2026

Cipla Discloses Crisil ESG Scores Under SEBI Rules - The Globe and Mail

The Globe and Mail - Jul 13, 2026

Biogen Expands Spinraza Patent Fight With Cipla, Somerset Suits - Bloomberg Law News

Bloomberg Law News - Jun 24, 2026

Cipla Receives U.S. FDA Approval for First AB-Rated Generic of Ventolin® HFA - Yahoo Finance

Yahoo Finance - Apr 23, 2026

Nifty 50 Gainers and Losers Today, July 17, 2026: Jio Financial, Kotak Mahindra Bank, HCLTech Among Gainers; Cipla, Wipro, Dr Reddy's Among Losers - HDFC Sky

HDFC Sky - Jul 17, 2026

Cipla Expands U.S. Respiratory Portfolio with Approval of Nintedanib Capsules (100mg & 150mg) for Idiopathic Pulmonary Fibrosis - PR Newswire

PR Newswire - Apr 02, 2026

India's Cipla posts steeper-than-expected quarterly profit slump on tumour drug supply crunch - Reuters

Reuters - Jan 23, 2026

Cipla Share Price Gains 4% As Citi Maintains Bullish Stance For 90-Day Momentum: Check Target Price - NDTV Profit

NDTV Profit - Jun 22, 2026

Cipla gains FDA OK for generic Ofev - Drug Store News

Drug Store News - Apr 03, 2026

Cipla Shares Slip Despite USFDA Nod for Generic Ventolin Inhaler; Should You Buy or Sell This Pharma Stock? - Goodreturns

Goodreturns - Jul 14, 2026

Lilly Sues Cipla to Block Copy of Breast Cancer Drug Verzenio - Bloomberg Law News

Bloomberg Law News - Jun 15, 2026

Cipla strengthens US portfolio with the launch of generic Saxenda® (Liraglutide Injection) for weight management therapy - PR Newswire

PR Newswire - Feb 27, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment